Bioidentical Hormone Replacement Therapy

New Data Shows Victoza® Helped Reduce Blood Sugar When Patients With Type 2 Diabetes Switched From Sitagliptin or …
SAN DIEGO, June 25, 2011 /PRNewswire/ — Novo Nordisk will present data from two extension studies at the 71st Annual Scientific Sessions of the American Diabetes Association (ADA) which show that Victoza® (liraglutide [rDNA origin] injection), taken once-daily, in combination with metformin and/or sulfonylurea, helped patients achieve blood sugar control after switching from other commonly used …
Hormone replacement therapy doubles breast cancer risk

This entry was posted on Saturday, February 3rd, 2007 at 4:32 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.